The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $1.6 million firm fixed price purchase order to Mediso USA LLC. The contract calls for Mediso to deliver one Multiscan LFER 150 PET/CT preclinical imaging system with 1mm resolution to accommodate rhesus macaques. Installation, training, a one-year warranty, and software upgrades are also included. This award fulfills a solicitation request from the NIH Molecular Imaging Branch...
This is a firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the National Institutes of Health (NIH), to Inscopix, Inc., a for-profit scientific instrumentation company. The contract has a total ceiling value of $87,593.00 and is for the provision of an INSCOPIX - VISTA HD 2.0 IN VIVO RODENT BRAIN IMAGING SYSTEM, which enables researchers to visualize and manipulate neural activity in living subjects with high-resolution,...
This firm fixed-price purchase order contract in the amount of $85,500.00 was awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the National Institutes of Health (NIH), to Inscopix, Inc., a for-profit scientific instrumentation company. The contract is for the provision of the NVISTA HD 2.0 IN VIVO RODENT BRAIN IMAGING SYSTEM, which enables advanced neuroscience research through specialized imaging and optogenetics technologies. This equipment supports cutting-edge...
This $106,500.00 firm fixed price purchase order was awarded by the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse to Inscopix, Inc., a for-profit corporation that provides scientific imaging systems, software, and services to support biomedical research. The contract does not have a set-aside designation. Inscopix has previously provided similar products and services, including its nVoke and nVista imaging and optogenetics systems, to...
The Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Drug Abuse awarded a $113,000.00 firm fixed-price purchase order to Inscopix, Inc., a for-profit organization, for the nVoke 2.0 Integrated Calcium Imaging and Optogenetics System for Rodents. This system will enable the NIH National Institute of Mental Health's (NIMH) Dendritic Dynamics Hub to expand its research on dendritic dynamics, neural circuit dynamics, and neuronal activity in awake,...
This is a federal contract award from the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Inscopix, Inc., a for-profit scientific instrumentation company in Mountain View, California. The contract, valued at $78,392.00, is for the procurement of an "NVOKE INTEGRATED IMAGING AND OPTOGENETICS SYSTEM FOR RODENTS." This equipment enables researchers to visualize and manipulate neural activity in living subjects, particularly rodents and...
This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD) to Life Molecular Imaging LIMITED, a UK-based manufacturer of radiopharmaceuticals and molecular imaging technologies. The $12,000 contract is for the delivery of FDA-approved radioligand doses to support medical research, specifically the Baltimore Longitudinal Study of Aging, which aims to characterize brain changes and understand aging processes. Life Molecular Imaging...
This is a Firm Fixed Price federal contract award by the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse to Inscopix, Inc., a for-profit provider of scientific imaging systems, software, and services for biomedical research. The contract has a potential value of $139,375.00 and a completion date of September 5, 2023. The contract is for the provision of Inscopix's nVoke and nVista lines of integrated imaging and optogenetics systems,...
This firm fixed-price purchase order contract, valued at $87,495.00, was awarded by the National Institute on Drug Abuse (NIDA), acting on behalf of the National Institute of Neurological Disorders and Stroke (NINDS), to Inscopix, Inc., a for-profit scientific instrumentation company based in Mountain View, California. The contract is for the delivery and installation of an Inscopix nVista 3.0 Imaging System, an application module, on-site training, and associated probes and software...
This is a federal contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The contract, with a ceiling value of $779,150.00, was awarded to Mediso USA, LLC, a for-profit limited liability company specializing in advanced medical imaging equipment and services for federal research institutions. The contract is a definitive, firm-fixed-price contract with an ultimate...
This contract was awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to Invicro LLC, a global contract research organization, to perform a full saturation radiography study for one compound. The contract is a firm-fixed-price purchase order with a potential value of $35,130.00. It does not have a set-aside designation. Invicro, which is owned by the Konica Corporation, has previously provided services such as full saturation radiography studies, in situ hybridization services, and imaging coordination and management to federal agencies including the NIH and the National Institute on Drug Abuse. This study aims to determine the occupancy of a known dopamine D3 receptor selective antagonist in D3 receptor-rich regions of the rat brain, as well as its selectivity over the D2 receptor, to support the development of novel D3 receptor antagonists for the treatment of psychostimulant addiction and relapse.